Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular characterization of TEM-59 (IRT-17), a novel inhibitor-resistant TEM-derived beta-lactamase in a clinical isolate of Klebsiella oxytoca.

Antimicrobial agents and chemotherapy - 1 Jul 1999

Bermudes H, Jude F, Chaibi E B, Arpin C, Bebear C, Labia R, Quentin C

Abstract excerpt

A clinical isolate of Klebsiella oxytoca (Kox 443) was found to have a low-level resistance to broad-spectrum penicillins (MICs of amoxicillin and ticarcillin, 256 and 32 microg/ml, respectively), without substantial potentiation by 2 microg of clavulanic acid per ml (amoxicillin- and ticarcillin-clavulanate, 128 and 8 microg/ml, respectively), while being fully susceptible to cephalosporins and other beta-lactam...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to beta-Lactamase Inhibitors

Share to beta-Lactamases

Share to Drug Resistance, Microbial

Share to Enzyme Inhibitors

Share to Klebsiella

Share to Polymerase Chain Reaction

Source

Open in PubMed Open full text

Identifiers

PMID: 10390218
DOI: 10.1128/AAC.43.7.1657
PMCID: PMC89339

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Molecular characterization of TEM-59 (IRT-17), a novel inhibitor-resistant TEM-derived beta-lactamase in a clinical isolate of Klebsiella oxytoca.PMID 10390218Read ↗

Inhibitor-resistant OXY-2-derived beta-lactamase produced by Klebsiella oxytoca.Semantic proximity Read ↗

Properties of IRT-14 (TEM-45), a newly characterized mutant of TEM-type beta-lactamases.Semantic proximity Read ↗

A novel complex mutant beta-lactamase, TEM-68, identified in a Klebsiella pneumoniae isolate from an outbreak of extended-spectrum beta-lactamase-producing Klebsiellae.Semantic proximity Read ↗

First report of a novel extended-spectrum beta-lactamase KOXY-2 producing Klebsiella oxytoca that hydrolyses cefotaxime and ceftazidime.Semantic proximity Read ↗

TEM-109 (CMT-5), a natural complex mutant of TEM-1 beta-lactamase combining the amino acid substitutions of TEM-6 and TEM-33 (IRT-5).Semantic proximity Read ↗

A complex mutant of TEM-1 beta-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate.Semantic proximity Read ↗

Characterization of a new TEM-derived beta-lactamase produced in a Serratia marcescens strain.Semantic proximity Read ↗

Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli.Semantic proximity Read ↗

Variability of chromosomally encoded beta-lactamases from Klebsiella oxytoca.Semantic proximity Read ↗

Construction and characterization of mutants of the TEM-1 beta-lactamase containing amino acid substitutions associated with both extended-spectrum resistance and resistance to beta-lactamase inhibitors.Semantic proximity Read ↗

Selection and characterization of beta-lactam-beta-lactamase inactivator-resistant mutants following PCR mutagenesis of the TEM-1 beta-lactamase gene.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.